LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 2 | E03 | 72 | hr | 1311 | 3678 | 5100 | 0.7212 | 0.6927 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 3 | E03 | 72 | hr | 1311 | 3519 | 5010 | 0.7023 | 0.6659 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1311 | 3178 | 4870 | 0.6525 | 0.5961 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1311 | 3318 | 4961 | 0.6687 | 0.6218 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1311 | 2862 | 4973 | 0.5754 | 0.5004 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1311 | 1916 | 5128 | 0.3736 | 0.2124 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1311 | 1709 | 5100 | 0.3351 | 0.1446 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1311 | 2117 | 5010 | 0.4225 | 0.2809 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP6 | 1 | C01 | 72 | hr | 1311 | 2157 | 4870 | 0.4429 | 0.3006 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP6 | 2 | C01 | 72 | hr | 1311 | 2183 | 4961 | 0.4400 | 0.3039 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP6 | 3 | C01 | 72 | hr | 1311 | 1854 | 4973 | 0.3728 | 0.1972 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP5 | 1 | E01 | 72 | hr | 1311 | 2786 | 5128 | 0.5433 | 0.4666 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP5 | 2 | E01 | 72 | hr | 1311 | 1752 | 5100 | 0.3435 | 0.1592 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP5 | 3 | E01 | 72 | hr | 1311 | 2045 | 5010 | 0.4081 | 0.2582 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 1311 | 5280 | 5128 | 1.0296 | 1.0298 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 1311 | 5012 | 5100 | 0.9828 | 0.9823 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 1311 | 5386 | 5010 | 1.0749 | 1.0761 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 1311 | 4966 | 5128 | 0.9683 | 0.9676 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 1311 | 4692 | 5100 | 0.9200 | 0.9167 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 1311 | 5184 | 5010 | 1.0346 | 1.0354 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 1311 | 5008 | 5128 | 0.9765 | 0.9760 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 1311 | 4679 | 5100 | 0.9175 | 0.9140 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 1311 | 5263 | 5010 | 1.0503 | 1.0514 |
MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1311 | 5226 | 5128 | 1.0190 | 1.0193 |
MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1311 | 4789 | 5100 | 0.9390 | 0.9368 |